We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Quarterly updates to the emergency presentations of cancer data by Public Health England.
Guidance on listed diseases of fish and shellfish and their status in England and Wales, including what happens if a disease is suspected or confirmed.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Information and resources to improve oral health and reduce inequalities in England.
A 4-year Retrospective Study at a Tertiary Cancer Center, Kerala, India
How to spot glanders and farcy, what to do if you suspect them and measures to prevent their spread.
Signs that may suggest rabies in bats, what to do if you spot them and measures to prevent exposing yourself to the disease.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Diseases and health problems in sheep and goats, including foot and mouth disease (FMD), scrapie and lead poisoning
Information for healthcare professionals, patients, and the public.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Information on depleted uranium (DU) including what it is, its uses, health effects and protection from exposure.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
The characteristics, diagnosis, management, surveillance and epidemiology of Pseudomonas aeruginosa.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Information for clinicians on the characteristics, diagnosis and epidemiology of infections caused by Chlamydia psittaci.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.